Exosomes from adipose-derived stem cells ameliorate phenotype of Huntington's disease in vitro model

European Journal of Neuroscience

Volumn 44, Issue 4, 2016, Pages 2114-2119

  Lee, Mijung ^a   Liu, Tian ^b   Im, Wooseok ^a   Kim, Manho ^a,c  

^a Seoul National University Hospital   (South Korea)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c Seoul National University   (South Korea)

Author keywords

adipose derived stem cells; exosomes; Huntington's disease; paracrine effect

Indexed keywords

CELL PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; HUNTINGTIN; PGC 1 PROTEIN; UNCLASSIFIED DRUG;

ADIPOSE DERIVED STEM CELL; ANIMAL CELL; APOPTOSIS; ARTICLE; BIOACCUMULATION; CELL FUNCTION; CELL PROTECTION; CELL SURVIVAL; CELL VIABILITY ASSAY; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EXOSOME; HUMAN; HUMAN CELL; HUNTINGTON CHOREA; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; MOUSE; NERVE CELL; NEUROPROTECTION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN PHOSPHORYLATION; STEM CELL TRANSPLANTATION; UPREGULATION; WESTERN BLOTTING;

EID: 84982227563     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/ejn.13275     Document Type: Article

References (32)

1. Arslan, F., Lai, R.C., Smeets, M.B., Akeroyd, L., Choo, A., Aguor, E.N., Timmers, L., van Rijen, H.V. et al. (2013) Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury. Stem Cell Res., 10, 301–312.
2. Atsma, D.E., Fibbe, W.E. & Rabelink, T.J. (2007) Opportunities and challenges for mesenchymal stem cell-mediated heart repair. Curr. Opin. Lipidol., 18, 645–649.
3. Bernal, D., Trelis, M., Montaner, S., Cantalapiedra, F., Galiano, A., Hackenberg, M. & Marcilla, A. (2014) Surface analysis of Dicrocoelium dendriticum. The molecular characterization of exosomes reveals the presence of miRNAs. J. Proteomics., 105, 232–241.
4. Browne, S.E. (2008) Mitochondria and Huntington's disease pathogenesis: insight from genetic and chemical models. Ann. N. Y. Acad. Sci., 1147, 358–382.
5. Davies, S.W., Turmaine, M., Cozens, B.A., DiFiglia, M., Sharp, A.H., Ross, C.A., Scherzinger, E., Wanker, E.E. et al. (1997) Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell, 90, 537–548.
6. Filosto, M., Scarpelli, M., Cotelli, M.S., Vielmi, V., Todeschini, A., Gregorelli, V., Tonin, P., Tomelleri, G. et al. (2011) The role of mitochondria in neurodegenerative diseases. J. Neurol., 258, 1763–1774.
7. Gnecchi, M., Zhang, Z., Ni, A. & Dzau, V.J. (2008) Paracrine mechanisms in adult stem cell signaling and therapy. Circ. Res., 103, 1204–1219.
8. Im, W., Ban, J., Lim, J., Lee, M., Lee, S.T., Chu, K. & Kim, M. (2013) Extracts of adipose derived stem cells slows progression in the R6/2 model of Huntington's disease. PLoS One, 8, e59438.
9. Im, W., Ban, J.J., Chung, J.Y., Lee, S.T., Chu, K. & Kim, M. (2015) Multidrug resistance protein 1 reduces the aggregation of mutant huntingtin in neuronal cells derived from the Huntington's disease R6/2 model. Sci. Rep., 5, 16887.
10. Jeon, G.S., Im, W., Shim, Y.M., Lee, M., Kim, M.J., Hong, Y.H., Seong, S.Y., Kim, M. et al. (2016) Neuroprotective effect of human adipose stem cell-derived extract in amyotrophic lateral sclerosis. Neurochem. Res., 41, 913–923.
11. Johri, A. & Beal, M.F. (2012) Mitochondrial dysfunction in neurodegenerative diseases. J. Pharmacol. Exp. Ther., 342, 619–630.
12. Keller, S., Sanderson, M.P., Stoeck, A. & Altevogt, P. (2006) Exosomes: from biogenesis and secretion to biological function. Immunol. Lett., 107, 102–108.
13. Kim, H.S., Lee, J.H., Han, H.D., Kim, A.R., Nam, S.T., Kim, H.W., Park, Y.H., Lee, D. et al. (2015) Autocrine stimulation of IL-10 is critical to the enrichment of IL-10-producing CD40(hi)CD5(+) regulatory B cells in vitro and in vivo. BMB Rep., 48, 54–59.
14. Lee, S.T., Chu, K., Jung, K.H., Im, W.S., Park, J.E., Lim, H.C., Won, C.H., Shin, S.H. et al. (2009) Slowed progression in models of Huntington disease by adipose stem cell transplantation. Ann. Neurol., 66, 671–681.
15. Lee, J.W., Fang, X., Krasnodembskaya, A., Howard, J.P. & Matthay, M.A. (2011) Concise review: Mesenchymal stem cells for acute lung injury: role of paracrine soluble factors. Stem Cells, 29, 913–919.
16. Lee, H.D., Kim, Y.H., Koo, B.H. & Kim, D.S. (2015) The ADAM15 ectodomain is shed from secretory exosomes. BMB Rep., 48, 277–282.
17. Liu, T., Im, W., Lee, S.T., Ban, J.J., Chai, Y.J., Lee, M., Mook-Jung, I., Chu, K. et al. (2014) Modulation of mitochondrial function by stem cell-derived cellular components. Biochem. Biophys. Res. Commun., 448, 403–408.
18. Lv, L.L., Cao, Y., Liu, D., Xu, M., Liu, H., Tang, R.N., Ma, K.L. & Liu, B.C. (2013) Isolation and quantification of microRNAs from urinary exosomes/microvesicles for biomarker discovery. Int. J. Biol. Sci., 9, 1021–1031.
19. Mathivanan, S., Ji, H. & Simpson, R.J. (2010) Exosomes: extracellular organelles important in intercellular communication. J. Proteomics., 73, 1907–1920.
20. McGill, J.K. & Beal, M.F. (2006) PGC-1alpha, a new therapeutic target in Huntington's disease? Cell, 127, 465–468.
21. Michael, A., Bajracharya, S.D., Yuen, P.S., Zhou, H., Star, R.A., Illei, G.G. & Alevizos, I. (2010) Exosomes from human saliva as a source of microRNA biomarkers. Oral Dis., 16, 34–38.
22. Mizuno, H. (2010) Adipose-derived stem and stromal cells for cell-based therapy: current status of preclinical studies and clinical trials. Curr. Opin. Mol. Ther., 12, 442–449.
23. Ohno, S., Takanashi, M., Sudo, K., Ueda, S., Ishikawa, A., Matsuyama, N., Fujita, K., Mizutani, T. et al. (2013) Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells. Mol. Ther., 21, 185–191.
24. Oliveira, J.M. (2010) Nature and cause of mitochondrial dysfunction in Huntington's disease: focusing on huntingtin and the striatum. J. Neurochem., 114, 1–12.
25. Panov, A.V., Gutekunst, C.A., Leavitt, B.R., Hayden, M.R., Burke, J.R., Strittmatter, W.J. & Greenamyre, J.T. (2002) Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines. Nat. Neurosci., 5, 731–736.
26. Park, Y.M. (2015) Oxidized LDL induces phosphorylation of non-muscle myosin IIA heavy chain in macrophages. BMB Rep., 48, 48–53.
27. van der Pol, E., Boing, A.N., Harrison, P., Sturk, A. & Nieuwland, R. (2012) Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol. Rev., 64, 676–705.
28. Prockop, D.J. (2009) Repair of tissues by adult stem/progenitor cells (MSCs): controversies, myths, and changing paradigms. Mol. Ther., 17, 939–946.
29. Rehman, J., Traktuev, D., Li, J., Merfeld-Clauss, S., Temm-Grove, C.J., Bovenkerk, J.E., Pell, C.L., Johnstone, B.H. et al. (2004) Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation, 109, 1292–1298.
30. Schaffler, A. & Buchler, C. (2007) Concise review: adipose tissue-derived stromal cells–basic and clinical implications for novel cell-based therapies. Stem Cells, 25, 818–827.
31. St-Pierre, J., Drori, S., Uldry, M., Silvaggi, J.M., Rhee, J., Jager, S., Handschin, C., Zheng, K. et al. (2006) Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell, 127, 397–408.
32. Vlassov, A.V., Magdaleno, S., Setterquist, R. & Conrad, R. (2012) Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim. Biophys. Acta, 1820, 940–948.